Article Cited by others

REVIEW ARTICLE

Oncogenic activation of ERG: A predominant mechanism in prostate cancer

Sreenath Taduru L, Dobi Albert, Petrovics Gyorgy, Srivastava Shiv

Year : 2011| Volume: 10| Issue : 1 | Page no: 37-37

   This article has been cited by
 
1 ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer
J R Gsponer,M Braun,V J Scheble,T Zellweger,A Bachmann,S Perner,T Vlajnic,M Srivastava,S-H Tan,A Dobi,I A Sesterhenn,S Srivastava,L Bubendorf,C Ruiz
Prostate Cancer and Prostatic Disease. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos
Eliza M. Raymundo,Michele H. Diwa,Marie Carmela M. Lapitan,Aladin B. Plaza,Jesus Emmanuel Sevilleja,Shiv Srivastava,Isabell A. Sesterhenn
The Prostate. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
3 Truncated ERG proteins affect the aggressiveness of prostate cancer
Fei Wu,Sentai Ding,Jiaju Lu
Medical Hypotheses. 2013; 80(4): 490
[Pubmed]  [Google Scholar] [DOI]
4 Genetic and molecular differences in prostate carcinogenesis between african american and caucasian american men
Farrell, J. and Petrovics, G. and Mcleod, D.G. and Srivastava, S.
International Journal of Molecular Sciences. 2013; 14(8): 15510-15531
[Pubmed]  [Google Scholar]
5 Truncated ERG proteins affect the aggressiveness of prostate cancer
Wu, F. and Ding, S. and Lu, J.
Medical Hypotheses. 2013; 80(4): 490-493
[Pubmed]  [Google Scholar]
6 Evaluation of ERG responsive proteome in prostate cancer
Shyh-Han Tan,Bungo Furusato,Xueping Fang,Fang He,Ahmed A. Mohamed,Nicholas B. Griner,Kaneeka Sood,Sadhvi Saxena,Shilpa Katta,Denise Young,Yongmei Chen,Taduru Sreenath,Gyorgy Petrovics,Albert Dobi,David G. McLeod,Isabell A. Sesterhenn,Satya Saxena,Shiv Srivastava
The Prostate. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
7 PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
Luciana Bueno Ferreira,Antonio Palumbo,Kivvi Duarte de Mello,Cinthya Sternberg,Mauricio S Caetano,Felipe Leite de Oliveira,Adriana Freitas Neves,Luiz Eurico Nasciutti,Luiz Ricardo Goulart,Etel Rodrigues Pereira Gimba
BMC Cancer. 2012; 12(1): 507
[Pubmed]  [Google Scholar] [DOI]
8 PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
Ferreira, L.B. and Palumbo, A. and de Mello, K.D. and Sternberg, C. and Caetano, M.S. and de Oliveira, F.L. and Neves, A.F. and Nasciutti, L.E. and Goulart, L.R. and Gimba, E.R.P.
BMC Cancer. 2012; 12(507)
[Pubmed]  [Google Scholar]
9 Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer
Flammiger, A. and Bayer, F. and Cirugeda-Kühnert, A. and Huland, H. and Tennstedt, P. and Simon, R. and Minner, S. and Bokemeyer, C. and Sauter, G. and Schlomm, T. and Trepel, M.
APMIS. 2012; 120(11): 901-908
[Pubmed]  [Google Scholar]
10 Personalized medicine for cancer in the developing world
Smith, R.E. and Pascale, J.M.
Current Trends in Biotechnology and Pharmacy. 2012; 6(2): 119-144
[Pubmed]  [Google Scholar]
11 Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer
Anna Flammiger,Florian Bayer,Ana Cirugeda-Kühnert,Hartwig Huland,Pierre Tennstedt,Ronald Simon,Sarah Minner,Carsten Bokemeyer,Guido Sauter,Thorsten Schlomm,Martin Trepel
APMIS. 2012; 120(11): 901
[Pubmed]  [Google Scholar] [DOI]

 

Read this article